Watson Recalls Diclofenac/Misoprostol Tablets Due to Splitting
Watson Laboratories recalls 5,987 bottles of Diclofenac Sodium and Misoprostol Delayed-Release Tablets due to split tablets found in stability samples.
Recall notice
Failed Tablet/Capsule Specifications: Split tablets were found in the 12-month stability samples.
Contact the company
What happened, in plain English
Watson Laboratories is recalling 5,987 bottles of Diclofenac Sodium and Misoprostol Delayed-Release Tablets because split tablets were discovered in 12-month stability samples. The affected product is a prescription-only medication manufactured by Watson Laboratories in Corona, CA. This recall was issued on December 20, 2013, and the products were distributed nationwide. Read more at govinfonow.com/recall/46350-watson-laboratories-inc-actavis-florida-recalls-diclofenac-sodium-and-misoprostol.
Source Summary by GovInfoNow · govinfonow.com/recall/46350-watson-laboratories-inc-actavis-florida-recalls-diclofenac-sodium-and-misoprostol · Updated October 13, 2026 · FDA enforcement record: FDA #D-1082-2014
Cite this page
“Watson Recalls Diclofenac/Misoprostol Tablets Due to Splitting.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46350-watson-laboratories-inc-actavis-florida-recalls-diclofenac-sodium-and-misoprostol. Based on FDA recall #D-1082-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1082-2014%22&limit=1).
Why it’s dangerous
The hazard involves failed tablet specifications where split tablets were found in stability samples. Splitting of delayed-release tablets can potentially compromise the drug's delivery mechanism, though the specific health consequences of this defect are not detailed in the record.
Who’s affected
Consumers who purchased the specific lot of prescription Diclofenac Sodium and Misoprostol Delayed-Release Tablets from Watson Laboratories between the manufacturing date and the recall announcement. Patients relying on this medication for its intended therapeutic effect may be affected if the tablets are split.
How to tell if you have this one
Check if you have a 60-count bottle of Diclofenac Sodium and Misoprostol Delayed-Release Tablets (75 mg/0.2 mg) manufactured by Watson Laboratories, Inc., Corona, CA 92880. Look for NDC 0591-0398-60, UPC 3 05910 39860 6, and Lot# 605957A with an expiration date of 09/14.
- Brand
Watson Laboratories- Product
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1082-2014 (December 20, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1082-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.